Post COVID-19 Organizing Pneumonia: The Right Time to Interfere

Post COVID-19 Organizing Pneumonia: The Right Time to Interfere

The COVID-19 pandemic dramatically changed medical care. Healthcare professionals are faced with new issues. Patients who survived COVID-19 have plenty of different continuing symptoms, of which the most common are fatigue and breathlessness. It is not well known how to care for patients with persis...

Full description

Bibliographic Details
Main Authors: Kristina Bieksiene, Jurgita Zaveckiene, Kestutis Malakauskas, Neringa Vaguliene, Marius Zemaitis, Skaidrius Miliauskas
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Medicina
Subjects:
COVID-19
viral pneumonia
organizing pneumonia
systemic glucocorticoids
interstitial lung diseases
Online Access:https://www.mdpi.com/1648-9144/57/3/283
id doaj-c1d6847ec3544d289fca1dc8132169c7
record_format Article
spelling doaj-c1d6847ec3544d289fca1dc8132169c72021-03-19T00:03:18ZengMDPI AGMedicina1010-660X1648-91442021-03-015728328310.3390/medicina57030283Post COVID-19 Organizing Pneumonia: The Right Time to InterfereKristina Bieksiene0Jurgita Zaveckiene1Kestutis Malakauskas2Neringa Vaguliene3Marius Zemaitis4Skaidrius Miliauskas5Department of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaDepartment of Radiology, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaDepartment of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaDepartment of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaDepartment of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaDepartment of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, LithuaniaThe COVID-19 pandemic dramatically changed medical care. Healthcare professionals are faced with new issues. Patients who survived COVID-19 have plenty of different continuing symptoms, of which the most common are fatigue and breathlessness. It is not well known how to care for patients with persistent or worsening respiratory symptoms and changes on chest X-ray following COVID-19 pneumonia. In this article, we talk about a subgroup of patients with organizing pneumonia following COVID-19 pneumonia that could be effectively treated with systemic glucocorticoids. It is important that patients with COVID-19 pneumonia be followed-up at least three weeks after diagnosis, in order to recognize early lung damage. We are providing a management algorithm for early diagnosis of lung diseases after COVID-19 pneumonia.https://www.mdpi.com/1648-9144/57/3/283COVID-19viral pneumoniaorganizing pneumoniasystemic glucocorticoidsinterstitial lung diseases
collection DOAJ
language English
format Article
sources DOAJ
author Kristina Bieksiene
Jurgita Zaveckiene
Kestutis Malakauskas
Neringa Vaguliene
Marius Zemaitis
Skaidrius Miliauskas
spellingShingle Kristina Bieksiene
Jurgita Zaveckiene
Kestutis Malakauskas
Neringa Vaguliene
Marius Zemaitis
Skaidrius Miliauskas
Post COVID-19 Organizing Pneumonia: The Right Time to Interfere
Medicina
COVID-19
viral pneumonia
organizing pneumonia
systemic glucocorticoids
interstitial lung diseases
author_facet Kristina Bieksiene
Jurgita Zaveckiene
Kestutis Malakauskas
Neringa Vaguliene
Marius Zemaitis
Skaidrius Miliauskas
author_sort Kristina Bieksiene
title Post COVID-19 Organizing Pneumonia: The Right Time to Interfere
title_short Post COVID-19 Organizing Pneumonia: The Right Time to Interfere
title_full Post COVID-19 Organizing Pneumonia: The Right Time to Interfere
title_fullStr Post COVID-19 Organizing Pneumonia: The Right Time to Interfere
title_full_unstemmed Post COVID-19 Organizing Pneumonia: The Right Time to Interfere
title_sort post covid-19 organizing pneumonia: the right time to interfere
publisher MDPI AG
series Medicina
issn 1010-660X
1648-9144
publishDate 2021-03-01
description The COVID-19 pandemic dramatically changed medical care. Healthcare professionals are faced with new issues. Patients who survived COVID-19 have plenty of different continuing symptoms, of which the most common are fatigue and breathlessness. It is not well known how to care for patients with persistent or worsening respiratory symptoms and changes on chest X-ray following COVID-19 pneumonia. In this article, we talk about a subgroup of patients with organizing pneumonia following COVID-19 pneumonia that could be effectively treated with systemic glucocorticoids. It is important that patients with COVID-19 pneumonia be followed-up at least three weeks after diagnosis, in order to recognize early lung damage. We are providing a management algorithm for early diagnosis of lung diseases after COVID-19 pneumonia.
topic COVID-19
viral pneumonia
organizing pneumonia
systemic glucocorticoids
interstitial lung diseases
url https://www.mdpi.com/1648-9144/57/3/283
work_keys_str_mv AT kristinabieksiene postcovid19organizingpneumoniatherighttimetointerfere
AT jurgitazaveckiene postcovid19organizingpneumoniatherighttimetointerfere
AT kestutismalakauskas postcovid19organizingpneumoniatherighttimetointerfere
AT neringavaguliene postcovid19organizingpneumoniatherighttimetointerfere
AT mariuszemaitis postcovid19organizingpneumoniatherighttimetointerfere
AT skaidriusmiliauskas postcovid19organizingpneumoniatherighttimetointerfere
_version_ 1724214858582327296

Similar Items